Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/CU6 stock hub

ASX/CU6 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/CU6is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/CU6

In the news

Latest news · ASX/CU6

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-53.4

P25 -118.7P50 -49.4P75 -1.2

ROIC-33.3

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/CU6 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

168

Groups with data

Currency

AUD

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	88
Employees Change	19%
Employees Change Percent	27.54
Enterprise value	AUD 857M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU0000165375
Last refreshed	2026-05-10
Market cap	AUD 1.1B
Price	AUD 2.91
Price currency	AUD
Rev Per Employee	120,225.51x
Sector	Healthcare
Sic	2834
Symbol	asx/CU6
Website	https://www.claritypharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.89%
EV Earnings	-8.9x
EV/FCF	-11.81x
EV/Sales	81.01x
FCF yield	-6.7%
P/B ratio	4.65x
P/S ratio	102.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	AUD 10.6M
Gross Profit Growth	11.8%
Gross Profit Growth Q	23.83%
Gross Profit Growth3 Y	-2.76%
Gross Profit Growth5 Y	1.54%
Net Income	AUD -96.3M
Net Income Growth Years	0%
Pretax Margin	-902.89%
Profit Per Employee	AUD -1.1M
ROA	-30.54
Roa5y	-26.86
ROCE	-41.12
ROE	-53.45
Roe5y	-47.65
ROIC	-33.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	20.76%
Cagr3y	57.28%
EPS Growth Years	0
Revenue Growth	-1.83x
Revenue Growth Q	23.83x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.76x
Revenue Growth5 Y	1.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.05
Assets	AUD 255.7M
Cash	AUD 226.2M
Current Assets	AUD 255M
Current Liabilities	AUD 22.3M
Equity	AUD 232.8M
Liabilities	AUD 22.9M
Long Term Assets	AUD 671,406
Long Term Liabilities	AUD 547,303
Net Cash	AUD 226.2M
Net Cash By Market Cap	AUD 20.89
Net Cash Growth	103.48%
Net Debt Equity	AUD -0.97
Tangible Book Value	AUD 232.8M
Tangible Book Value Per Share	AUD 0.63
WACC	10.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.43
Net Working Capital	AUD 6.4M
Quick ratio	10.9
Working Capital	AUD 232.7M
Working Capital Turnover	AUD 0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.88%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	20.75%
200-day SMA	3.63
3Y total return	289.21%
50-day SMA	3.23
50-day SMA vs 200-day SMA	50under200
All Time High	8.98
All Time High Change	-67.58%
All Time High Date	2024-09-23
All Time Low	0.36
All Time Low Change	708.33%
All Time Low Date	2022-06-23
ATR	0.21
Beta	1.2
Beta1y	0.22
Beta2y	1.15
Ch YTD	-13.91
High	2.93
High52	5.87
High52 Date	2025-10-14
High52ch	-50.43%
Low	2.85
Low52	1.84
Low52 Date	2025-06-02
Low52ch	58.15%
Ma50ch	-9.94%
Price vs 200-day SMA	-19.88%
RSI	44.9
RSI Monthly	47.27
RSI Weekly	42.52
Sharpe ratio	0.69x
Sortino ratio	1.2
Total Return	-13.88%
Tr YTD	-13.91
Tr1m	-4.59%
Tr1w	0.34%
Tr3m	6.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -96M
Operating margin	-907

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	265,552,911%
Shares Insiders	13.05%
Shares Institutions	26.85%
Shares Out	372,258,073
Shares Qo Q	13.25%
Shares Yo Y	13.88%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -78.7M
Average Volume	2,842,319.85x
Bv Per Share	0.63
CAPEX	AUD -336,728
Ch1m	-4.59
Ch1w	0.34
Ch1y	20.75
Ch3m	6.59
Ch3y	288
Ch6m	-35.9
Change	-1.69%
Change From Open	0.69
Close	2.96
Days Gap	-2.36
Depreciation Amortization	248,878
Dollar Volume	4,086,710.9
Earnings Date	2026-05-27
EBIT	AUD -96M
EBITDA	AUD -95.7M
EPS	AUD -0.28
F Score	2
FCF	AUD -72.6M
FCF EV Yield	-8.47x
FCF Per Share	AUD -0.2
Financing CF	193,445,889
Fiscal Year End	June
Founded	2,010
Income Tax	AUD 722,863
Investing CF	-47,912,162
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Ma150	3.62
Ma150ch	-19.68%
Ma20	3
Ma20ch	-3.06%
Net CF	67,481,415
Next Earnings Date	2026-05-27
Open	2.89
Position In Range	75
Ppne	657,592
Price Date	2026-05-08
Ptbv Ratio	4.65
Relative Volume	0.49x
Revenue	10,579,845x
SBC By Revenue	57.89x
Share Based Comp	6,124,579
Tax By Revenue	6.83x
Tr6m	-35.9%
Volume	1,404,368
Z Score	28.72

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/CU6 pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/CU6 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/CU6?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.9%

Share of float held by funds and institutions

Insider ownership

+13.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+13.9%

Negative means the company is buying back shares.

Technical

ASX/CU6 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.9

Neutral momentum band

Price vs 200-day MA

-19.9%

50/200-day relationship not available

Beta (5Y)

1.20

Moves roughly with the market

Sharpe ratio

0.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/CU6

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/CU6 stock rating?

asx/CU6 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/CU6 analysis?

The full report lives at /stocks/asx/CU6/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/CU6?

The latest report frames asx/CU6 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/CU6 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.